ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. Issue 11 (17th March 2021)

• Record Type: Journal Article
• Authors: Rayner, Stephanie L; Cheng, Flora; Hogan, Alison L; Grima, Natalie; Yang, Shu; Ke, Yazi D; Au, Carol G; Morsch, Marco; De Luca, Alana; Davidson, Jennilee M; Molloy, Mark P; Shi, Bingyang; Ittner, Lars M; Blair, Ian; Chung, Roger S; Lee, Albert
• Is Part Of: Human molecular genetics. Volume 30:Issue 11(2021)
• Page Start: 971
• Page End: 984
• Publication Date: 2021-03-17
• Subjects: Human molecular genetics -- Periodicals; Human chromosome abnormalities -- Periodicals; 572.8
• DOI: 10.1093/hmg/ddab073
• Languages: English
• ISSNs: 0964-6906

Abstract

Abstract: Previously, we identified missense mutations in CCNF that are causative of familial and sporadic amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Hallmark features of these diseases include the build-up of insoluble protein aggregates as well as the mislocalization of proteins such as transactive response DNA binding protein 43 kDa (TDP-43). In recent years, the dysregulation of SFPQ (splicing factor proline and glutamine rich) has also emerged as a pathological hallmark of ALS/FTD. CCNF encodes for the protein cyclin F, a substrate recognition component of an E3 ubiquitin ligase. We have previously shown that ALS/FTD-linked mutations in CCNF cause disruptions to overall protein homeostasis that leads to a build-up of K48-linked ubiquitylated proteins as well as defects in autophagic machinery. To investigate further processes that may be affected by cyclin F, we used a protein-proximity ligation method, known as Bio tin Id entification (BioID), standard immunoprecipitations and mass spectrometry to identify novel interaction partners of cyclin F and infer further process that may be affected by the ALS/FTD-causing mutation. Results demonstrate that cyclin F closely associates with proteins involved with RNA metabolism as well as a number of RNA-binding proteins previously linked to ALS/FTD, including SFPQ. Notably, the overexpression of cyclin F(S621G) led to the aggregation and altered subcellular distribution of SFPQ in human embryonic kidney (HEK293) cells, while leading to altered degradation in primary neurons. Overall, our data links ALS/FTD-causing mutations in CCNF to converging pathological features of ALS/FTD and provides a link between defective protein degradation systems and the pathological accumulation of a protein involved in RNA processing and metabolism.